Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 3.2900 |
| Open | 3.3000 |
| Bid | 3.3900 x 500 |
| Ask | 3.4200 x 1000 |
| Day's Range | 3.2100 - 3.5600 |
| 52 Week Range | 3.2100 - 37.9800 |
| Volume | |
| Avg. Volume | 1,838,168 |
| Market Cap | 354.334M |
| Beta (5Y Monthly) | 1.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.8300 |
| Earnings Date | May 06, 2024 - May 21, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.91 |
- Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Simply Wall St.Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Key Insights Institutions' substantial holdings in Revance Therapeutics implies that they have significant influence...
- Business Wire
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NASHVILLE, Tenn., March 27, 2024--Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
© 2024 Yahoo. All rights reserved.